{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T04:04:39Z","timestamp":1720238679770},"reference-count":3,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ijcard.2018.12.023","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T09:54:51Z","timestamp":1552730091000},"page":"135","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u0392eta-blocker therapy in cocaine-associated heart failure: Attempting to mitigate the risk"],"prefix":"10.1016","volume":"283","author":[{"given":"Nicholas C.","family":"Schwier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.12.023_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2018.08.058","article-title":"Clinical outcomes of Beta-blocker therapy in cocaine-associated heart failure","volume":"277","author":"Lopez","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.12.023_bb0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2018.10.003","article-title":"Beta-blockers: a real antidote for cocaine-related heart disease?","volume":"277","author":"Barison","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.12.023_bb0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318368153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318368153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T00:30:13Z","timestamp":1561163413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318368153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":3,"alternative-id":["S0167527318368153"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.12.023","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u0392eta-blocker therapy in cocaine-associated heart failure: Attempting to mitigate the risk","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}